PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.
NCT02787837
·
clinicaltrials.gov ↗
UNKNOWN
Status
220
Enrollment
OTHER
Sponsor class
Conditions
Advanced Prostate Cancer
Abiraterone ACetate
Sponsor
Centro Nacional de Investigaciones Oncologicas CARLOS III